BIOLIFE SOLUTIONS INC — Director's Dealing 2023

Mar 10, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2023-03-07

Reporting Person: Mathew Aby J. (EVP & Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-07	Common Stock	S	415	$22.95	Disposed	271186	Direct

Footnotes

F1: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.